SCHEMBL6994334

SCHEMBL6994334

COc1ccc2c3c(sc2c1)Nc1cc(F)ccc1NC3=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 3/20 0.42
ALDH1A1 P00352 2/20 0.40
MIF P14174 3/20 0.39
PMM2 O15305 2/20 0.39
MPI P34949 2/20 0.39
PHOSPHO1 Q8TCT1 2/20 0.39
CDK4 P11802 2/20 0.38
CCND1 P24385 2/20 0.38
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
CHEK1 O14757 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
CLK1 P49759 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KDR P35968 1/20 0.36
PRNP P04156 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6990964 0.88 MAPT (0.40) ALDH1A1MIFMPICDK4CCND1
SCHEMBL6993147 0.87 CDK4 (0.43) MDM2ALDH1A1CDK4CCND1PDE3B
SCHEMBL6998266 0.84 CSNK1G1 (0.38) ALDH1A1PMM2MPIPHOSPHO1NPC1
SCHEMBL6992702 0.83 TGM2 (0.37) ALDH1A1MIFCDK4CCND1MEN1
SCHEMBL6988596 0.82 CSNK1G1 (0.41) ALDH1A1PMM2MPIPHOSPHO1CDK4
SCHEMBL6995200 0.82 ALDH1A1 (0.49) ALDH1A1CDK4CCND1CHEK1NPC1
SCHEMBL6996333 0.80 MAPT (0.44) ALDH1A1CDK4CCND1CHEK1MEN1
SCHEMBL6993425 0.80 MAPT (0.44) ALDH1A1CDK4CCND1CHEK1MEN1
SCHEMBL6997151 0.80 CCNE2 (0.40) ALDH1A1MIFMPIPHOSPHO1CDK4
SCHEMBL6993139 0.77 CSNK1G1 (0.38) ALDH1A1PMM2MPIPHOSPHO1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1016664-B1 FUSED THIOPHENE COMPOUNDS AND MEDICINAL USE THEREOF MITSUBISHI PHARMA CORP (JP) 2003-07-02 EP claimed
US-20020042411-A1 Condensed thiophene compounds and pharmaceutical use thereof MITSUBISHI PHARMA CORPORATION (JP) 2002-04-11 US claimed
US-6271225-B1 PSYCHOLOGICAL DISORDERS WELFIDE CORPORATION (JP) 2001-08-07 US claimed
EP-1016664-A1 FUSED THIOPHENE COMPOUNDS AND MEDICINAL USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2000-07-05 EP claimed
EP-1016664-B1 FUSED THIOPHENE COMPOUNDS AND MEDICINAL USE THEREOF MITSUBISHI PHARMA CORP (JP) 2003-07-02 EP disclosed
US-6455521-B1 PSYCHOLOGICAL DISORDERS; SIDE EFFECT REDUCTION MITSUBISHI PHARMA CORPORATION (JP) 2002-09-24 US disclosed
US-20020042411-A1 Condensed thiophene compounds and pharmaceutical use thereof MITSUBISHI PHARMA CORPORATION (JP) 2002-04-11 US disclosed
US-6271225-B1 PSYCHOLOGICAL DISORDERS WELFIDE CORPORATION (JP) 2001-08-07 US disclosed
EP-1016664-A1 FUSED THIOPHENE COMPOUNDS AND MEDICINAL USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2000-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042411-A1 Condensed thiophene compounds and pharmaceutical use thereof ACIN1, ACHE, TPMT MDM2 3561/4885ALDH1A1 366/4885MIF 1021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.